Wong Jerome 4

What Happened Jerome Wong, Chief Financial Officer of Ekso Bionics Holdings, Inc. (EKSO), acquired 1,308 shares on March 16, 2026 at $11.85 per share for a total value of approximately $15,500. The transaction was a purchase (code P) and the shares were received as part of the issuer’s 401(k) contribution matching program, rather than a discretionary open-market buy by the officer.

Key Details

• Transaction date and price: 2026-03-16, 1,308 shares at $11.85 each (total ≈ $15,500).
• Transaction type: Purchase (P) — shares acquired in connection with the company’s 401(k) matching program (Footnote F1).
• Shares owned after transaction: Not specified in the provided summary.
• Filing: Form 4 filed on 2026-03-20 (four calendar days after the transaction); this appears to be past the standard two-business-day filing deadline for Form 4s.
• Reverse split note: Reported amounts have been adjusted for the 1-for-15 reverse stock split effective June 2, 2025 (Footnote F2).

Context This was a routine employer 401(k) match contribution, which is generally considered administrative rather than a direct signal of insider conviction. Purchases are often more informative than sales, but employer matching contributions typically reflect plan activity rather than timed insider buying. The late filing may be procedural and could warrant monitoring for timeliness in future reports.